by Richard G. Hamermesh - Publications - Faculty & Research - Harvard Business School

Filter Results: (228)

Filter Results: (228)

Show Results For

← Page 6 of 228 Results →

Are you looking for?

→Search All HBS Web

January 2007
Background Note

Note on Biotech Business Development

By: Richard G. Hamermesh and Robert F. Higgins

Describes the business development process in biotechnology companies. Topics covered include: participants in the licensing process and their interests, the major steps in the licensing process, the terms that are part of most agreements, and the most contentious... View Details

Keywords: Agreements and Arrangements; Entrepreneurship; Intellectual Property; Biotechnology Industry

December 2006
Supplement

Dental Corp--video

By: Richard G. Hamermesh

Keywords: Media; Health Industry

November 2006 (Revised May 2007)
Supplement

Corporate Venture Capital at Eli Lilly

By: Richard G. Hamermesh

Keywords: Management; Business Ventures; Pharmaceutical Industry

October 2006 (Revised August 2007)
Case

Calloway Laboratory: Pee for Profit

By: Richard G. Hamermesh and David Kiron

Describes the formation and rapid growth of a drug-testing company. The company needs to decide whether to enter the painkiller testing market, in addition to growing its drug treatment center business. View Details

Keywords: For-Profit Firms; Health Care and Treatment; Health Testing and Trials; Growth and Development Strategy; Market Entry and Exit; Health Industry

September 2006
Teaching Note

Corporate Venture Capital at Eli Lilly (TN)

By: Richard G. Hamermesh and Erin Seefeld

Keywords: Venture Capital; Pharmaceutical Industry

September 2006
Supplement

Wu Xi Pharmatech

By: Richard G. Hamermesh

Keywords: Pharmaceutical Industry

June 2006
Supplement

Cutlass Capital, L.P.: Discussion with David Hetz and Jon Osgood

By: Richard G. Hamermesh

Keywords: Capital; Financial Services Industry

2006
Book

New Business Ventures and the Entrepreneur

By: Michael J. Roberts, Howard H. Stevenson, William A. Sahlman, Paul Marshall and Richard G. Hamermesh

Keywords: Entrepreneurship

Find at Harvard

May 2006
Teaching Note

WuXi PharmaTech (TN)

By: Richard G. Hamermesh and Erin Seefeld

Keywords: Pharmaceutical Industry

March 2006
Teaching Note

Cutlass Capital, L.P. (TN)

By: Richard G. Hamermesh and Erin Seefeld

Teaching Note to 805075. View Details

Keywords: Financial Services Industry

March 2006
Teaching Note

Conor Medsystems (TN)

By: Robert F. Higgins, Richard G. Hamermesh and Erin Seefeld

Teaching Note to (804-180). View Details

Keywords: Health Industry

March 2006
Teaching Note

Stan Lapidus: Profile of a Medical Entrepreneur (TN)

By: Robert F. Higgins, Richard G. Hamermesh and Erin Seefeld

Teaching Note to (805-087). View Details

Keywords: Personal Development and Career; Entrepreneurship; Business Startups; Biotechnology Industry; Pharmaceutical Industry

March 2006
Teaching Note

Fred Khosravi and AccessClosure (TN)

By: Richard G. Hamermesh and Erin Seefeld

Teaching Note to (806-044). View Details

Keywords: Entrepreneurship; Decision Choices and Conditions; Mergers and Acquisitions; Business Exit or Shutdown; Initial Public Offering; Medical Devices and Supplies Industry

March 2006 (Revised February 2009)
Teaching Note

Molecular Insight Pharmaceuticals, Inc. (TN)

By: Richard G. Hamermesh and Erin Seefeld

Teaching Note to (805-067). View Details

Keywords: Pharmaceutical Industry

February 2006
Teaching Note

John Moran and the Orthopedics Industry (TN)

By: Richard G. Hamermesh

Teaching Note to 805026. View Details

Keywords: Health Industry

January 2006 (Revised May 2007)
Case

Endo Pharmaceuticals (A): From LBO to...?

By: Richard G. Hamermesh and Brian DeLacey

Endo Pharmaceuticals was formed in 1997 as a leveraged buyout spin-off from DuPont Merck. In 1999, it must decide whether to do an IPO or merge with a smaller company. View Details

Keywords: Private Equity; Initial Public Offering; Leveraged Buyouts; Mergers and Acquisitions; Health Care and Treatment; Pharmaceutical Industry; United States

January 2006 (Revised May 2007)
Supplement

Endo Pharmaceuticals (B): Merger Decision

By: Richard G. Hamermesh and Brian DeLacey

Keywords: Mergers and Acquisitions; Pharmaceutical Industry

January 2006 (Revised May 2007)
Supplement

Endo Pharmaceuticals (C): An "At Risk" Launch?

By: Richard G. Hamermesh and Brian DeLacey

Keywords: Product Launch; Risk and Uncertainty; Pharmaceutical Industry

January 2006 (Revised May 2007)
Supplement

Endo Pharmaceuticals (D): Hatch-Waxman Change

By: Richard G. Hamermesh and Brian DeLacey

Keywords: Change; Pharmaceutical Industry

January 2006 (Revised May 2007)
Supplement

Endo Pharmaceuticals (E): Judge Stein Rules

By: Richard G. Hamermesh and Brian DeLacey

Keywords: Lawsuits and Litigation; Pharmaceutical Industry

←
6
7
…
11
12
→